APA (7th ed.) Citation

Hulot, J., Bura, A., Villard, E., Azizi, M., Remones, V., Goyenvalle, C., . . . Gaussem, P. (2006). Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood, 108(7), 2244-2247. https://doi.org/10.1182/blood-2006-04-013052

Chicago Style (17th ed.) Citation

Hulot, Jean-Sébastien, Alessandra Bura, Eric Villard, Michel Azizi, Véronique Remones, Catherine Goyenvalle, Martine Aiach, Philippe Lechat, and Pascale Gaussem. "Cytochrome P450 2C19 Loss-of-function Polymorphism Is a Major Determinant of Clopidogrel Responsiveness in Healthy Subjects." Blood 108, no. 7 (2006): 2244-2247. https://doi.org/10.1182/blood-2006-04-013052.

MLA (9th ed.) Citation

Hulot, Jean-Sébastien, et al. "Cytochrome P450 2C19 Loss-of-function Polymorphism Is a Major Determinant of Clopidogrel Responsiveness in Healthy Subjects." Blood, vol. 108, no. 7, 2006, pp. 2244-2247, https://doi.org/10.1182/blood-2006-04-013052.